 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|
   |
| August 2017 Another Record Revenue Month for MJNA |
|
 Hot Stock to Watch |
Company: Medical Marijuana, Inc. (Pink Sheets: MJNA)
|
Last:
Price: 0.0815
Change (%): + 0.0007 (0.87)
Volume: 2,361,067 |
 |
Medical Marijuana, Inc. Announces that August 2017 was the Largest Revenue Sales Month in Company History
Medical Marijuana, Inc. Wholly Owned Subsidiaries Kannaway® and HempMeds® Mexico Had the Largest Sales Month in August Since Companies Were Founded
SAN DIEGO, Sept. 11, 2017 /PRNewswire/ - Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that August 2017 was the Company’s largest revenue month in its history. Additionally, wholly-owned subsidiaries Kannaway® and HempMeds® Mexico experienced their largest months of revenue in their respective histories.
“Kannaway’s growth has been particularly stunning since it’s re-launch in March 2016,” said Kannaway CEO, Blake Schroeder. “Kannaway’s revenue has increased over 25 times during that time-period, and the company intends to launch a series of new products in Q4 2017 as it gears up for its regional convention this fall in Denver, Co. Additionally, there are plans to launch into Europe later this year. We fully expect Kannaway’s aggressive growth to continue!”
“As we continue to expand into new markets, we are proud to watch the Company achieve milestone after milestone,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Our portfolio of companies continues to create exciting developments in the cannabidiol (CBD) sector. Medical Marijuana, Inc. and our portfolio of companies are on track for a banner year, in terms of gross sales revenue figures.”
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
